In its updated guidelines for colon cancer1and for rectal cancer2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value. This represents a significant step forward as it’s the first time the committee has fo...
This selection from the NCCN Guidelines for Rectal Cancer focuses on management of malignant polyps and resectable nonmetastatic rectal cancer because important updates have been made to these guidelines. These recent updates include redrawing the algorithms for stage II and III disease to reflect new ...
Rectal cancer is one of the leading causes of cancer mortality in both men and women worldwide. Multimodal management with chemotherapy, radiotherapy, and surgical resection remain the mainstay in rectal cancer treatment. The optimal use and timing of these treatment modalities are evolving. Ongoing ...
today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for colon cancer, rectal cancer, and merkel cell carcinoma (MCC). ...
NCCN Guidelinesand this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Rectal Cancer Version 1.2021 — December 22, 2020 NCCN.org NCCN Guidelines for Patients? available at /patients ...
RectalCancer Version4.2011 Continue IMPORTANTNOTEREGARDING LEUCOVORINSHORTAGE, PLEASESEEMS-9 NCCN ® Version4.2011,02/25/11©NationalComprehensiveCancerNetwork,Inc.2011,Allrightsreserved.TheNCCNGuidelines™andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN®. ...
Georgiou P, Tan E, Gouvas N et al (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10(11):1053–1062 Article PubMed Google Scholar Benson AB, Venook AP, Al-Hawary MM et al (2022) Rectal cancer, version 2.2022, NCCN clinical ...
Locally advanced rectal cancer nCRT: Neoadjuvant chemoradiotherapy 5FU: 5-fluorouracil CRT: Chemoradiotherapy RT: Radiotherapy OS: Overall survival DFS: Disease-free survival pCR: Pathologic complete response CRC: Colorectal cancer TNT: Total neoadjuvant therapy NCCN: NATIONAL Comprehensive ...
Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:1139–67. Article CAS PubMed Google Scholar Souza da Silva RM, Queiroga EM, Paz AR, Neves FF, Cunha KS, Dias EP. Standardized assessment of the tumor-stroma ratio in colorectal...
In China, the ratio of rectal cancer to colon cancer in terms of incidence is close to 1: 1. Low rectal cancer accounts for more than half of all cases of rectal cancer. In recent years, the proportion of rectal cancer has trended downward, however the incidence of rectal cancer in ...